SCHEMBL16475654

SCHEMBL16475654

C=C(OC)c1ccc(C=O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.62
▸ CYP2A6 P11509 3/20 0.48
▸ ALDH5A1 P51649 2/20 0.43
▸ ABAT P80404 2/20 0.43
▸ PARP10 Q53GL7 1/20 0.43
▸ PARP3 Q9Y6F1 1/20 0.43
▸ AOX1 Q06278 1/20 0.40
▸ TRIM24 O15164 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40
▸ ALDH1A3 P47895 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP2A13 Q16696 1/20 0.39
▸ ADRB2 P07550 1/20 0.39
▸ ADRB1 P08588 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17677417 0.81 ALDH1A1 (0.48) ALDH1A1HPGDTDP1TSHRKDM4E
SCHEMBL25218257 0.79 ALDH1A1 (0.47) ALDH1A1CYP2A6ALDH5A1ABATPARP10
SCHEMBL28139530 0.79 ALDH1A1 (0.61) ALDH1A1CYP2A6ALDH5A1ABATPARP10
SCHEMBL79533 0.77 ALDH1A1 (1.00) ALDH1A1TDP1TSHR
SCHEMBL28033399 0.77 ALDH1A1 (1.00) ALDH1A1TDP1TSHR
SCHEMBL15990409 0.76 ALDH1A1 (0.53) ALDH1A1CYP2A6ALDH5A1ABATPARP10
SCHEMBL47357 0.76 CYP2A6 (0.54) ALDH1A1CYP2A6ALDH5A1ABATPARP10
SCHEMBL28435221 0.73 ALDH1A1 (0.66) ALDH1A1CYP2A6ALDH5A1ABATPARP10
SCHEMBL20442261 0.73 TDP1 (0.38) ALDH1A1TDP1TSHR
SCHEMBL13459853 0.73 CA12 (0.54) ALDH1A1AOX1HPGDTSHRTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140107166-A1 HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2014-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107166-A1 HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF HDAC1, HDAC5, HDAC11 ALDH1A1 364/4885CYP2A6 2798/4885ALDH5A1 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback